Basilea Pharmaceutica AG (SWX: BSLN)
45.40
-0.15 (-0.33%)
Sep 4, 2024, 5:30 PM CET
Basilea Pharmaceutica AG Revenue
Basilea Pharmaceutica AG had revenue of 31.84M CHF in the half year ending June 30, 2024, with 205.43% growth. This brings the company's revenue in the last twelve months to 52.54M, up 157.23% year-over-year. In the year 2023, Basilea Pharmaceutica AG had annual revenue of 33.56M with 86.61% growth.
Revenue (ttm)
52.54M
Revenue Growth
+157.23%
P/S Ratio
3.68
Revenue / Employee
955.27K
Employees
147
Market Cap
552.12M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBasilea Pharmaceutica AG News
- 19 days ago - Basilea Pharmaceutica Ltd (BPMUF) (Q2 2024) Earnings Call Transcript Highlights: Strong Revenue ... - GuruFocus
- 19 days ago - Half Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript - GuruFocus
- 22 days ago - Basilea Pharmaceutica AG (BPMUF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Basilea Pharmaceutica GAAP EPS of CHF 1.61, revenue of CHF 76.3M; raises FY24 outlook - Seeking Alpha
- 5 months ago - US FDA approves Basilea Pharmaceutica's antibiotic - Reuters
- 7 months ago - Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio - GlobeNewsWire
- 1 year ago - Basilea announces repayment of 2022 convertible bonds - GlobeNewsWire
- 2 years ago - Basilea Pharmaceutica (BSLN): Renewed Focus on Anti-Infectives - Accesswire